文献速递免疫规划传染病防控与疫情报告

双脯氨酸稳定化猪流行性腹泻病毒全长刺突mRNA疫苗免疫原性与保护效力优于传统灭活疫苗

Double proline- substituted porcine epidemic diarrhea virus full-length spike mRNA vaccine confers enhanced immunogenicity and protective efficacy compared to conventional inactivated vaccine.
PubMed 文献 · Vaccine · 2026-05-16

本研究从中国广西腹泻暴发中分离G2c基因型PEDV毒株23GXNN-1,构建编码野生型S蛋白(S-WT)及双脯氨酸稳定化突变(S-2P,I1076P/L1077P)的mRNA疫苗。在BALB/c小鼠、母猪和仔猪中评估显示,S-2P LNP-mRNA疫苗诱导更强的体液与细胞免疫,母源免疫通过初乳抗体转移使强毒攻击仔猪获得100%存活,优于商品化灭活疫苗。

要点

  • S-2P mRNA疫苗诱导的IgG/IgA和中和抗体水平及细胞免疫均优于S-WT。
  • 母猪免疫S-2P后通过初乳被动转移抗体,使强毒攻击仔猪100%存活。
  • S-2P保护效力优于商品化灭活疫苗,但疫苗对肠道菌群多样性保护有限。

核心结论

  • S-2P LNP-mRNA疫苗是控制PEDV的有前景候选,母源免疫对新生仔猪保护至关重要。

研究设计与样本

  • 从中国广西腹泻暴发中分离PEDV毒株23GXNN-1(G2c基因型),构建S-WT与S-2P(I1076P/L1077P)两种mRNA疫苗候选。
  • 在HEK293T细胞及BALB/c小鼠、母猪和仔猪模型中评估免疫原性与保护效力。

主要发现

  • S-2P LNP-mRNA疫苗较S-WT诱导更强的体液免疫(IgG/IgA滴度和中和抗体升高)及增强的细胞免疫应答。
  • 母猪免疫S-2P后,通过初乳高效被动转移抗体,使强毒PEDV G2c攻击仔猪获得100%存活,优于商品化灭活疫苗。
  • 疫苗对感染期间肠道菌群多样性和肠道屏障完整性的保护有限,但母源抗体有效降低疾病严重程度。

临床怎么用

  • 针对PEDV G2c流行株,可优先考虑双脯氨酸稳定化全长S mRNA疫苗作为母猪免疫策略。
  • 母猪免疫应关注初乳抗体被动转移对新生仔猪的保护作用。

局限性

  • 疫苗对感染期间肠道菌群多样性和肠道屏障完整性的保护有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Porcine epidemic diarrhea virus (PEDV) is a highly contagious pathogen causing near 100% mortality in neonatal piglets, posing a persistent threat to the global swine industry. In this study, we isolated a PEDV strain, 23GXNN-1 (genotype G2c), from an outbreak in Guangxi, China. Two mRNA vaccine candidates were developed: one encoding the wild-type spike (S) protein S-WT and another incorporating proline-stabilized mutations (S-2P, I1076P/L1077P). Evaluations in HEK293T cells and animal models (BALB/c mice, sows, and piglets) revealed that the S-2P LNP-mRNA vaccine induced superior immunogenicity compared to S-WT, generating robust humoral immunity (elevated IgG/IgA titers and neutralizing antibodies) and enhanced cellular immune responses. Notably, maternal immunization with S-2P conferred 100% survival in piglets challenged with virulent PEDV G2c via efficient passive transfer of antibodies through colostrum, outperforming commercial inactivated vaccines. While vaccines provide limited protection to gut microbiota diversity and intestinal barrier integrity during infection, maternally derived antibodies effectively reduce disease severity. This study not only identifies S-2P as a promising candidate for PEDV control, but also underscores the crucial role of maternal immunity in neonatal protection, advancing mRNA-based strategies against enteric coronaviruses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zeng L, Pan D, Huang Y, et al. Double proline- substituted porcine epidemic diarrhea virus full-length spike mRNA vaccine confers enhanced immunogenicity and protective efficacy compared to conventional inactivated vaccine. Vaccine. 2026. PMID: 42142524. doi:10.1016/j.vaccine.2026.128699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。